Application 207580
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AUROVELA FE 1.5/30 | ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | TABLET;ORAL-28 | 0.03MG;1.5MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-941 | AUROVELA Fe | Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate | Aurobindo Pharma Limited | ANDA | Current |